AXT, Inc. 10-Q Summary
Business Context and Reporting Period
AXT, Inc. develops and manufactures compound and single-element semiconductor substrates, including indium phosphide, gallium arsenide and germanium wafers, and sells related raw materials such as purified gallium and pyrolytic boron nitride crucibles. All products are manufactured in China through consolidated subsidiaries and joint ventures. The filing covers the unaudited three months ended March 31, 2023, compared with the three months ended March 31, 2022.
Key Financial Metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $19.4 million | $39.7 million | Down 51.1% |
| Gross profit | $5.1 million | $13.3 million | Down 61.6% |
| Gross margin | 26.3% | 33.6% | Down 7.3 percentage points |
| Operating income (loss) | $(4.4) million | $3.7 million | Declined $8.1 million |
| Operating margin | (22.9%) | 9.3% | Down 32.2 percentage points |
| Net income (loss) | $(3.7) million | $4.0 million | Declined $7.6 million |
| Net loss attributable to AXT | $(3.3) million | $3.2 million | Loss versus profit |
| Diluted EPS | $(0.08) | $0.07 | Declined $0.15 |
| Net cash used in operating activities | $(1.5) million | $(8.9) million | Improved $7.4 million |
| Capital expenditures | $3.6 million | $6.3 million | Down $2.7 million |
Substrate revenue was $13.5 million, down 57.5%, primarily because of weaker InP demand in data center, consumer and telecommunications markets and weaker GaAs demand, particularly in China. Raw materials revenue was $5.9 million, down 25.2%, mainly due to lower pBN crucible and refined gallium sales.
Operating expenses were $9.5 million, broadly unchanged from $9.6 million in the prior-year period. SG&A decreased 7.7% to $6.0 million, while research and development increased 13.8% to $3.6 million, reflecting development of 8-inch GaAs and 6-inch InP substrates and related product features. Interest expense increased to $397,000 from $183,000 due to higher debt. Equity income from unconsolidated joint ventures was $1.0 million, compared with $1.1 million.
As of March 31, 2023, total assets were $366.6 million, including $35.4 million of cash and cash equivalents, $9.5 million of restricted cash, $7.0 million of short-term investments and $1.6 million of long-term investments. Total cash, restricted cash, cash equivalents and investments were $53.6 million, compared with $52.8 million at December 31, 2022. Accounts receivable declined to $21.3 million from $29.3 million, while inventory increased to $91.7 million from $89.6 million.
Bank loans totaled $52.8 million at March 31, 2023, compared with $47.1 million at December 31, 2022. Most loans mature within 12 months and carry stated interest rates generally ranging from 2.4% to 4.8%. Total liabilities were $78.3 million, and redeemable noncontrolling interests were $44.9 million.
Material Changes Versus the Prior Comparable Period
- Revenue fell 51.1% across all geographic regions, with the largest declines in China, Taiwan and Europe.
- Gross margin contracted because lower demand reduced factory utilization and caused under-absorption of fixed manufacturing overhead. InP material recycling provided partial cost savings.
- The company shifted from operating profit and net income in Q1 2022 to operating and net losses in Q1 2023.
- Operating cash usage improved substantially, principally because accounts receivable declined and working-capital outflows were lower than in the prior year.
- Research and development spending increased despite the revenue decline, supporting larger-diameter GaAs and InP products.
- Inventory reserves for excess and obsolete inventory increased to $25.9 million from $24.7 million at year-end 2022. Accrued product warranty liabilities increased to $915,000 from $669,000, primarily due to increased claims for quality issues experienced by a customer.
- U.S. tariffs on imported wafers were approximately $447,000 in Q1 2023.
Guidance, Outlook, Commentary, Risks and Unusual Items
The filing does not provide a clear numerical revenue or earnings outlook. Management states that it expects adequate cash and investments to meet operating needs and capital expenditures for the next twelve months, but cautions that further sales declines could accelerate cash usage and require additional capital.
Management attributes the downturn to weaker semiconductor and end-market demand, including softness in data centers, telecommunications, consumer applications and China. The company expects cyclical demand fluctuations to continue and emphasizes that fixed manufacturing costs make factory utilization important to future gross margins.
Tongmei’s proposed IPO on the Shanghai Stock Exchange STAR Market remained subject to review and approval by the China Securities Regulatory Commission and other authorities. Investors in Tongmei have redemption rights at an aggregate amount of approximately $49 million if the IPO fails specified conditions or is canceled. This represents a material potential liquidity contingency.
Significant risks include Chinese regulatory intervention, environmental or pollution-related shutdowns, geopolitical and trade tensions, tariffs and export restrictions, foreign-exchange volatility, customer qualification and product-quality requirements, semiconductor industry cyclicality, excess inventory, dependence on Chinese manufacturing and suppliers, and the potential underutilization of new GaAs facilities. The company reported no material legal proceedings, no off-balance-sheet financing arrangements and effective disclosure controls.
Subsequent events included $1.8 million dividends from each of two equity investment entities in April 2023, an approximately $730,000 Chinese government innovation subsidy received by ChaoYang XinMei, and a May 2023 agreement to sell a 15% interest in Emeishan JiaMei for approximately $875,000.
Most Important Facts for Investors to Verify
- Whether demand for InP and GaAs substrates recovers and whether revenue stabilizes after the sharp Q1 decline.
- Factory utilization, product yields, customer qualification progress and the effect of fixed manufacturing costs on gross margin.
- The level and aging of inventory, including the $25.9 million excess and obsolete inventory reserve.
- The maturity schedule, refinancing requirements and collateral arrangements for the $52.8 million of bank loans.
- The status and timing of Tongmei’s STAR Market IPO and the probability and funding implications of potential redemption claims of approximately $49 million.
- Cash availability within China, foreign-exchange restrictions and the company’s ability to transfer funds through its corporate structure.
- The impact of U.S. tariffs, China-U.S. trade restrictions and any future regulatory or environmental actions in China.
- Warranty claims, product-quality trends and any additional customer returns or qualification delays.